article · Journal of Integrated Health Sciences
Background: A significant gap exists between the intention and actual use of long-acting reversible contraception (LARC) postpartum despite their effectiveness. LARC use remains low in low- and middle-income countries, including Buea and Limbe, Cameroon. Aim: This study examines the prevalence, barriers, and factors influencing LARC use among postpartum women in this region, aiming to inform health interventions. Materials and Methods: A hospital-based cross-sectional survey was conducted among 205 postpartum women at Buea and Limbe regional hospitals between February 1, 2024, and April 30, 2024. Data were collected on sociodemographic characteristics, reproductive history, family planning knowledge, and LARC use. Logistic regression analysis was used to identify factors associated with LARC use. Results: Of the 205 women, 34% were using LARC (81.4% implants and 18.6% IUDs). Fear of side effects (41.5%) and concerns about duration of effectiveness (13.2%) were the primary barriers to LARC use. Positive perceptions about LARC, including its lack of interference with sexual intercourse (53.7%) and cancer risk (50.2%), were common. Protestant women (adjusted odds ratio [AOR] =2.27, P = 0.015) and employed women (AOR = 4.19, P = 0.009) were more likely to use LARC. Women who did not receive counseling were less likely to adopt LARC (AOR = 0.04, P = 0.001). Conclusion: Utilization rate of LARC during postpartum remains low (34%) among women attending the regional hospitals of Southwest. Comprehensive counseling during antenatal care and the immediate postpartum period is crucial for increasing LARC uptake among these women. Addressing concerns about side effects and the duration of effectiveness is essential for promoting LARC adoption.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4103/jihs.jihs_49_25
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.